CATH Superfamily 1.20.1250.10
The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was: waiting to be named.
FunFam 11: Interleukin-10
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 11 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Interleukin-10 receptor binding GO:0005141
Interacting selectively and non-covalently with the interleukin-10 receptor.
|
6 | P22301 (/NAS) P22301 (/NAS) P22301 (/NAS) P48411 (/NAS) P51746 (/NAS) Q29408 (/NAS) |
Cytokine activity GO:0005125
Functions to control the survival, growth, differentiation and effector function of tissues and cells.
|
3 | P22301 (/NAS) P22301 (/NAS) P22301 (/NAS) |
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
3 | P22301 (/IPI) P22301 (/IPI) P22301 (/IPI) |
Growth factor activity GO:0008083
The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation.
|
3 | P22301 (/NAS) P22301 (/NAS) P22301 (/NAS) |
Protein dimerization activity GO:0046983
The formation of a protein dimer, a macromolecular structure consists of two noncovalently associated identical or nonidentical subunits.
|
3 | P22301 (/IDA) P22301 (/IDA) P22301 (/IDA) |
Cytokine activity GO:0005125
Functions to control the survival, growth, differentiation and effector function of tissues and cells.
|
1 | P18893 (/IDA) |
Cytokine activity GO:0005125
Functions to control the survival, growth, differentiation and effector function of tissues and cells.
|
1 | P18893 (/IMP) |
Interleukin-10 receptor binding GO:0005141
Interacting selectively and non-covalently with the interleukin-10 receptor.
|
1 | P29456 (/IDA) |
Interleukin-10 receptor binding GO:0005141
Interacting selectively and non-covalently with the interleukin-10 receptor.
|
1 | P29456 (/IMP) |
Interleukin-10 receptor binding GO:0005141
Interacting selectively and non-covalently with the interleukin-10 receptor.
|
1 | P18893 (/ISO) |
Protein dimerization activity GO:0046983
The formation of a protein dimer, a macromolecular structure consists of two noncovalently associated identical or nonidentical subunits.
|
1 | P18893 (/ISO) |
There are 144 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Response to molecule of bacterial origin GO:0002237
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of bacterial origin such as peptides derived from bacterial flagellin.
|
37 |
A2T6Z6 (/ISS)
P29456 (/ISS)
P43480 (/ISS)
P46651 (/ISS)
P47965 (/ISS)
P48411 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
(27 more) |
Negative regulation of cytokine secretion involved in immune response GO:0002740
Any process that stops, prevents, or reduces the frequency, rate, or extent of cytokine secretion contributing to an immune response.
|
37 |
A2T6Z6 (/ISS)
P29456 (/ISS)
P43480 (/ISS)
P46651 (/ISS)
P47965 (/ISS)
P48411 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
(27 more) |
Positive regulation of B cell apoptotic process GO:0002904
Any process that activates or increases the frequency, rate, or extent of B cell apoptotic process.
|
37 |
A2T6Z6 (/ISS)
P29456 (/ISS)
P43480 (/ISS)
P46651 (/ISS)
P47965 (/ISS)
P48411 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
(27 more) |
Inflammatory response GO:0006954
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
|
37 |
A2T6Z6 (/ISS)
P29456 (/ISS)
P43480 (/ISS)
P46651 (/ISS)
P47965 (/ISS)
P48411 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
(27 more) |
Negative regulation of B cell proliferation GO:0030889
Any process that stops, prevents or reduces the rate or extent of B cell proliferation.
|
37 |
A2T6Z6 (/ISS)
P29456 (/ISS)
P43480 (/ISS)
P46651 (/ISS)
P47965 (/ISS)
P48411 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
(27 more) |
Negative regulation of interleukin-6 production GO:0032715
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-6 production.
|
37 |
A2T6Z6 (/ISS)
P29456 (/ISS)
P43480 (/ISS)
P46651 (/ISS)
P47965 (/ISS)
P48411 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
(27 more) |
Receptor biosynthetic process GO:0032800
The chemical reactions and pathways resulting in the formation of a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
37 |
A2T6Z6 (/ISS)
P29456 (/ISS)
P43480 (/ISS)
P46651 (/ISS)
P47965 (/ISS)
P48411 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
(27 more) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
37 |
A2T6Z6 (/ISS)
P29456 (/ISS)
P43480 (/ISS)
P46651 (/ISS)
P47965 (/ISS)
P48411 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
(27 more) |
Positive regulation of cytokine secretion GO:0050715
Any process that activates or increases the frequency, rate or extent of the regulated release of cytokines from a cell.
|
37 |
A2T6Z6 (/ISS)
P29456 (/ISS)
P43480 (/ISS)
P46651 (/ISS)
P47965 (/ISS)
P48411 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
(27 more) |
Negative regulation of membrane protein ectodomain proteolysis GO:0051045
Any process that stops, prevents, or reduces the frequency, rate or extent of membrane protein ectodomain proteolysis.
|
37 |
A2T6Z6 (/ISS)
P29456 (/ISS)
P43480 (/ISS)
P46651 (/ISS)
P47965 (/ISS)
P48411 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
(27 more) |
Positive regulation of DNA-binding transcription factor activity GO:0051091
Any process that activates or increases the frequency, rate or extent of activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
|
37 |
A2T6Z6 (/ISS)
P29456 (/ISS)
P43480 (/ISS)
P46651 (/ISS)
P47965 (/ISS)
P48411 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
(27 more) |
Response to glucocorticoid GO:0051384
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects.
|
37 |
A2T6Z6 (/ISS)
P29456 (/ISS)
P43480 (/ISS)
P46651 (/ISS)
P47965 (/ISS)
P48411 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
(27 more) |
Negative regulation of interleukin-1 production GO:0032692
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-1 production.
|
8 | P22301 (/TAS) P22301 (/TAS) P22301 (/TAS) Q6FGS9 (/TAS) Q6FGW4 (/TAS) Q6FGW4 (/TAS) Q6FGW4 (/TAS) Q71UZ1 (/TAS) |
Negative regulation of interleukin-12 production GO:0032695
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-12 production.
|
8 | P22301 (/TAS) P22301 (/TAS) P22301 (/TAS) Q6FGS9 (/TAS) Q6FGW4 (/TAS) Q6FGW4 (/TAS) Q6FGW4 (/TAS) Q71UZ1 (/TAS) |
Negative regulation of interleukin-18 production GO:0032701
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-18 production.
|
8 | P22301 (/TAS) P22301 (/TAS) P22301 (/TAS) Q6FGS9 (/TAS) Q6FGW4 (/TAS) Q6FGW4 (/TAS) Q6FGW4 (/TAS) Q71UZ1 (/TAS) |
Negative regulation of interleukin-6 production GO:0032715
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-6 production.
|
8 | P22301 (/TAS) P22301 (/TAS) P22301 (/TAS) Q6FGS9 (/TAS) Q6FGW4 (/TAS) Q6FGW4 (/TAS) Q6FGW4 (/TAS) Q71UZ1 (/TAS) |
Negative regulation of interleukin-8 production GO:0032717
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-8 production.
|
8 | P22301 (/TAS) P22301 (/TAS) P22301 (/TAS) Q6FGS9 (/TAS) Q6FGW4 (/TAS) Q6FGW4 (/TAS) Q6FGW4 (/TAS) Q71UZ1 (/TAS) |
Negative regulation of tumor necrosis factor production GO:0032720
Any process that stops, prevents, or reduces the frequency, rate, or extent of tumor necrosis factor production.
|
8 | P22301 (/TAS) P22301 (/TAS) P22301 (/TAS) Q6FGS9 (/TAS) Q6FGW4 (/TAS) Q6FGW4 (/TAS) Q6FGW4 (/TAS) Q71UZ1 (/TAS) |
Negative regulation of chemokine (C-C motif) ligand 5 production GO:0071650
Any process that stops, prevents, or reduces the frequency, rate, or extent of production of chemokine (C-C motif) ligand 5.
|
8 | P22301 (/TAS) P22301 (/TAS) P22301 (/TAS) Q6FGS9 (/TAS) Q6FGW4 (/TAS) Q6FGW4 (/TAS) Q6FGW4 (/TAS) Q71UZ1 (/TAS) |
Negative regulation of cytokine production GO:0001818
Any process that stops, prevents, or reduces the rate of production of a cytokine.
|
3 | P22301 (/IDA) P22301 (/IDA) P22301 (/IDA) |
Response to molecule of bacterial origin GO:0002237
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of bacterial origin such as peptides derived from bacterial flagellin.
|
3 | P22301 (/IDA) P22301 (/IDA) P22301 (/IDA) |
Negative regulation of cytokine secretion involved in immune response GO:0002740
Any process that stops, prevents, or reduces the frequency, rate, or extent of cytokine secretion contributing to an immune response.
|
3 | P22301 (/IDA) P22301 (/IDA) P22301 (/IDA) |
Positive regulation of B cell apoptotic process GO:0002904
Any process that activates or increases the frequency, rate, or extent of B cell apoptotic process.
|
3 | P22301 (/IDA) P22301 (/IDA) P22301 (/IDA) |
Inflammatory response GO:0006954
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
|
3 | P22301 (/IDA) P22301 (/IDA) P22301 (/IDA) |
Cytoplasmic sequestering of NF-kappaB GO:0007253
The selective interaction of the transcription factor NF-kappaB with specific molecules in the cytoplasm, thereby inhibiting its translocation into the nucleus.
|
3 | P22301 (/NAS) P22301 (/NAS) P22301 (/NAS) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
3 | P22301 (/ISS) P22301 (/ISS) P22301 (/ISS) |
Regulation of gene expression GO:0010468
Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
3 | P22301 (/IDA) P22301 (/IDA) P22301 (/IDA) |
Negative regulation of autophagy GO:0010507
Any process that stops, prevents, or reduces the frequency, rate or extent of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm.
|
3 | P22301 (/IDA) P22301 (/IDA) P22301 (/IDA) |
Cytokine-mediated signaling pathway GO:0019221
A series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
3 | P22301 (/TAS) P22301 (/TAS) P22301 (/TAS) |
Hemopoiesis GO:0030097
The process whose specific outcome is the progression of the myeloid and lymphoid derived organ/tissue systems of the blood and other parts of the body over time, from formation to the mature structure. The site of hemopoiesis is variable during development, but occurs primarily in bone marrow or kidney in many adult vertebrates.
|
3 | P22301 (/TAS) P22301 (/TAS) P22301 (/TAS) |
B cell differentiation GO:0030183
The process in which a precursor cell type acquires the specialized features of a B cell. A B cell is a lymphocyte of B lineage with the phenotype CD19-positive and capable of B cell mediated immunity.
|
3 | P22301 (/NAS) P22301 (/NAS) P22301 (/NAS) |
Leukocyte chemotaxis GO:0030595
The movement of a leukocyte in response to an external stimulus.
|
3 | P22301 (/TAS) P22301 (/TAS) P22301 (/TAS) |
Negative regulation of B cell proliferation GO:0030889
Any process that stops, prevents or reduces the rate or extent of B cell proliferation.
|
3 | P22301 (/IDA) P22301 (/IDA) P22301 (/IDA) |
Negative regulation of interleukin-6 production GO:0032715
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-6 production.
|
3 | P22301 (/IDA) P22301 (/IDA) P22301 (/IDA) |
Receptor biosynthetic process GO:0032800
The chemical reactions and pathways resulting in the formation of a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
3 | P22301 (/IDA) P22301 (/IDA) P22301 (/IDA) |
Negative regulation of heterotypic cell-cell adhesion GO:0034115
Any process that stops, prevents, or reduces the frequency, rate, or extent of heterotypic cell-cell adhesion.
|
3 | P22301 (/ISS) P22301 (/ISS) P22301 (/ISS) |
Positive regulation of heterotypic cell-cell adhesion GO:0034116
Any process that activates or increases the frequency, rate, or extent of heterotypic cell-cell adhesion.
|
3 | P22301 (/ISS) P22301 (/ISS) P22301 (/ISS) |
Interleukin-12-mediated signaling pathway GO:0035722
A series of molecular signals initiated by the binding of interleukin-12 to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
3 | P22301 (/TAS) P22301 (/TAS) P22301 (/TAS) |
Type 2 immune response GO:0042092
An immune response which is associated with resistance to extracellular organisms such as helminths and pathological conditions such as allergy, which is orchestrated by the production of particular cytokines, most notably IL-4, IL-5, IL-10, and IL-13, by any of a variety of cell types including T-helper 2 cells, eosinophils, basophils, mast cells, and nuocytes, resulting in enhanced production of certain antibody isotypes and other effects.
|
3 | P22301 (/TAS) P22301 (/TAS) P22301 (/TAS) |
B cell proliferation GO:0042100
The expansion of a B cell population by cell division. Follows B cell activation.
|
3 | P22301 (/NAS) P22301 (/NAS) P22301 (/NAS) |
Negative regulation of T cell proliferation GO:0042130
Any process that stops, prevents or reduces the rate or extent of T cell proliferation.
|
3 | P22301 (/NAS) P22301 (/NAS) P22301 (/NAS) |
Defense response to protozoan GO:0042832
Reactions triggered in response to the presence of a protozoan that act to protect the cell or organism.
|
3 | P18893 (/IDA) Q6A2H4 (/IDA) Q6A2H4 (/IDA) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
3 | P22301 (/NAS) P22301 (/NAS) P22301 (/NAS) |
Negative regulation of nitric oxide biosynthetic process GO:0045019
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide.
|
3 | P29456 (/IDA) Q6A2H4 (/IDA) Q6A2H4 (/IDA) |
Regulation of isotype switching GO:0045191
Any process that modulates the frequency, rate or extent of isotype switching.
|
3 | P22301 (/NAS) P22301 (/NAS) P22301 (/NAS) |
Negative regulation of MHC class II biosynthetic process GO:0045347
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of MHC class II.
|
3 | P22301 (/IDA) P22301 (/IDA) P22301 (/IDA) |
Negative regulation of MHC class II biosynthetic process GO:0045347
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of MHC class II.
|
3 | P22301 (/TAS) P22301 (/TAS) P22301 (/TAS) |
Negative regulation of interferon-alpha biosynthetic process GO:0045355
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interferon-alpha.
|
3 | P22301 (/NAS) P22301 (/NAS) P22301 (/NAS) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
3 | P22301 (/IDA) P22301 (/IDA) P22301 (/IDA) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
3 | P22301 (/IMP) P22301 (/IMP) P22301 (/IMP) |
Negative regulation of mitotic cell cycle GO:0045930
Any process that stops, prevents or reduces the rate or extent of progression through the mitotic cell cycle.
|
3 | P22301 (/ISS) P22301 (/ISS) P22301 (/ISS) |
Positive regulation of receptor signaling pathway via JAK-STAT GO:0046427
Any process that activates or increases the frequency, rate or extent of the JAK-STAT signaling pathway activity.
|
3 | P22301 (/IDA) P22301 (/IDA) P22301 (/IDA) |
Positive regulation of cytokine secretion GO:0050715
Any process that activates or increases the frequency, rate or extent of the regulated release of cytokines from a cell.
|
3 | P22301 (/IDA) P22301 (/IDA) P22301 (/IDA) |
Negative regulation of inflammatory response GO:0050728
Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response.
|
3 | P22301 (/NAS) P22301 (/NAS) P22301 (/NAS) |
Negative regulation of membrane protein ectodomain proteolysis GO:0051045
Any process that stops, prevents, or reduces the frequency, rate or extent of membrane protein ectodomain proteolysis.
|
3 | P22301 (/IDA) P22301 (/IDA) P22301 (/IDA) |
Positive regulation of DNA-binding transcription factor activity GO:0051091
Any process that activates or increases the frequency, rate or extent of activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
|
3 | P22301 (/IDA) P22301 (/IDA) P22301 (/IDA) |
Response to glucocorticoid GO:0051384
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects.
|
3 | P22301 (/IDA) P22301 (/IDA) P22301 (/IDA) |
Negative regulation of cytokine activity GO:0060302
Any process that decreases the rate, frequency or extent of the activity of a molecule that controls the survival, growth, differentiation and effector function of tissues and cells.
|
3 | P22301 (/IMP) P22301 (/IMP) P22301 (/IMP) |
Cellular response to lipopolysaccharide GO:0071222
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
3 | P22301 (/NAS) P22301 (/NAS) P22301 (/NAS) |
Endothelial cell apoptotic process GO:0072577
Any apoptotic process in an endothelial cell. An endothelial cell comprises the outermost layer or lining of anatomical structures and can be squamous or cuboidal.
|
3 | P22301 (/ISS) P22301 (/ISS) P22301 (/ISS) |
Regulation of response to wounding GO:1903034
Any process that modulates the frequency, rate or extent of response to wounding.
|
3 | P22301 (/ISS) P22301 (/ISS) P22301 (/ISS) |
Negative regulation of hydrogen peroxide-induced neuron death GO:1903208
Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide-induced neuron death.
|
3 | P22301 (/ISS) P22301 (/ISS) P22301 (/ISS) |
Negative regulation of vascular smooth muscle cell proliferation GO:1904706
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell proliferation.
|
3 | P22301 (/ISS) P22301 (/ISS) P22301 (/ISS) |
Positive regulation of vascular smooth muscle cell proliferation GO:1904707
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell proliferation.
|
3 | P22301 (/ISS) P22301 (/ISS) P22301 (/ISS) |
Negative regulation of T-helper 1 type immune response GO:0002826
Any process that stops, prevents, or reduces the frequency, rate, or extent of a T-helper 1 type immune response.
|
2 | Q6A2H4 (/IC) Q6A2H4 (/IC) |
Defense response to protozoan GO:0042832
Reactions triggered in response to the presence of a protozoan that act to protect the cell or organism.
|
2 | Q6A2H4 (/NAS) Q6A2H4 (/NAS) |
Negative regulation of interferon-gamma biosynthetic process GO:0045077
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interferon-gamma.
|
2 | Q6A2H4 (/IDA) Q6A2H4 (/IDA) |
Negative regulation of interferon-alpha secretion GO:1902740
Any process that stops, prevents or reduces the frequency, rate or extent of interferon-alpha secretion.
|
2 | Q29408 (/IDA) Q6H8Q2 (/IDA) |
Negative regulation of cytokine production GO:0001818
Any process that stops, prevents, or reduces the rate of production of a cytokine.
|
1 | P29456 (/IMP) |
Negative regulation of cytokine production GO:0001818
Any process that stops, prevents, or reduces the rate of production of a cytokine.
|
1 | P18893 (/ISO) |
Positive regulation of endothelial cell proliferation GO:0001938
Any process that activates or increases the rate or extent of endothelial cell proliferation.
|
1 | P18893 (/IGI) |
Response to molecule of bacterial origin GO:0002237
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of bacterial origin such as peptides derived from bacterial flagellin.
|
1 | P18893 (/ISO) |
Negative regulation of cytokine secretion involved in immune response GO:0002740
Any process that stops, prevents, or reduces the frequency, rate, or extent of cytokine secretion contributing to an immune response.
|
1 | P18893 (/ISO) |
Negative regulation of chronic inflammatory response to antigenic stimulus GO:0002875
Any process that stops, prevents, or reduces the frequency, rate, or extent of a chronic inflammatory response to an antigenic stimulus.
|
1 | P18893 (/IMP) |
Positive regulation of B cell apoptotic process GO:0002904
Any process that activates or increases the frequency, rate, or extent of B cell apoptotic process.
|
1 | P18893 (/ISO) |
Inflammatory response GO:0006954
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
|
1 | P18893 (/ISO) |
Immune response GO:0006955
Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
|
1 | P29456 (/IMP) |
Immune response GO:0006955
Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
|
1 | P18893 (/ISO) |
Aging GO:0007568
A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
|
1 | P29456 (/IEP) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
1 | P18893 (/IMP) |
Response to organic substance GO:0010033
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus.
|
1 | P29456 (/IEP) |
Regulation of gene expression GO:0010468
Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
1 | P18893 (/ISO) |
Negative regulation of autophagy GO:0010507
Any process that stops, prevents, or reduces the frequency, rate or extent of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm.
|
1 | P18893 (/ISO) |
Response to activity GO:0014823
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an activity stimulus.
|
1 | P29456 (/IEP) |
Response to inactivity GO:0014854
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an inactivity stimulus.
|
1 | P29456 (/IEP) |
Antigen processing and presentation of exogenous peptide antigen via MHC class II GO:0019886
The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein.
|
1 | P48411 (/NAS) |
Negative regulation of myeloid dendritic cell activation GO:0030886
Any process that stops, prevents, or reduces the frequency, rate or extent of myeloid dendritic cell activation.
|
1 | P18893 (/IMP) |
Negative regulation of B cell proliferation GO:0030889
Any process that stops, prevents or reduces the rate or extent of B cell proliferation.
|
1 | P18893 (/ISO) |
Response to lipopolysaccharide GO:0032496
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
1 | Q5EFQ8 (/IDA) |
Response to lipopolysaccharide GO:0032496
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
1 | P29456 (/IEP) |
Negative regulation of interferon-gamma production GO:0032689
Any process that stops, prevents, or reduces the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.
|
1 | P18893 (/IMP) |
Negative regulation of interleukin-12 production GO:0032695
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-12 production.
|
1 | P18893 (/IMP) |
Negative regulation of interleukin-6 production GO:0032715
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-6 production.
|
1 | P18893 (/ISO) |
Negative regulation of tumor necrosis factor production GO:0032720
Any process that stops, prevents, or reduces the frequency, rate, or extent of tumor necrosis factor production.
|
1 | P18893 (/IMP) |
Receptor biosynthetic process GO:0032800
The chemical reactions and pathways resulting in the formation of a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
1 | P18893 (/ISO) |
Response to insulin GO:0032868
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.
|
1 | P29456 (/IEP) |
Negative regulation of heterotypic cell-cell adhesion GO:0034115
Any process that stops, prevents, or reduces the frequency, rate, or extent of heterotypic cell-cell adhesion.
|
1 | P18893 (/IGI) |
Response to carbon monoxide GO:0034465
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a carbon monoxide (CO) stimulus.
|
1 | P29456 (/IEP) |
Cellular response to hepatocyte growth factor stimulus GO:0035729
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hepatocyte growth factor stimulus.
|
1 | P18893 (/IDA) |
Interferon-gamma biosynthetic process GO:0042095
The chemical reactions and pathways resulting in the formation of interferon-gamma. Interferon gamma is the only member of the type II interferon found so far.
|
1 | P43480 (/IMP) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
1 | P29456 (/IEP) |
Negative regulation of tumor necrosis factor biosynthetic process GO:0042536
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of tumor necrosis factor, an inflammatory cytokine produced by macrophages/monocytes during acute inflammation and which is responsible for a diverse range of signaling events within cells, leading to necrosis or apoptosis.
|
1 | P29456 (/IDA) |
Negative regulation of tumor necrosis factor biosynthetic process GO:0042536
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of tumor necrosis factor, an inflammatory cytokine produced by macrophages/monocytes during acute inflammation and which is responsible for a diverse range of signaling events within cells, leading to necrosis or apoptosis.
|
1 | P18893 (/ISO) |
Defense response to bacterium GO:0042742
Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism.
|
1 | P18893 (/IDA) |
Defense response to bacterium GO:0042742
Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism.
|
1 | Q5EFQ8 (/IMP) |
Positive regulation of macrophage activation GO:0043032
Any process that stimulates, induces or increases the rate of macrophage activation.
|
1 | P29456 (/IDA) |
Positive regulation of macrophage activation GO:0043032
Any process that stimulates, induces or increases the rate of macrophage activation.
|
1 | P18893 (/ISO) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
1 | P29456 (/IMP) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
1 | P18893 (/ISO) |
Negative regulation of growth of symbiont in host GO:0044130
Any process in which the symbiont stops, prevents or reduces its increase in size or mass within the cells or tissues of the host organism. The host is defined as the larger of the organisms involved in the symbiotic interaction.
|
1 | P18893 (/IMP) |
Negative regulation of nitric oxide biosynthetic process GO:0045019
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide.
|
1 | P18893 (/ISO) |
Negative regulation of nitric oxide biosynthetic process GO:0045019
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide.
|
1 | P43480 (/NAS) |
Negative regulation of interferon-gamma biosynthetic process GO:0045077
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interferon-gamma.
|
1 | P43480 (/NAS) |
Negative regulation of MHC class II biosynthetic process GO:0045347
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of MHC class II.
|
1 | P18893 (/ISO) |
Positive regulation of MHC class II biosynthetic process GO:0045348
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of MHC class II.
|
1 | P18893 (/IDA) |
Positive regulation of cell cycle GO:0045787
Any process that activates or increases the rate or extent of progression through the cell cycle.
|
1 | P18893 (/IGI) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
1 | P18893 (/ISO) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
1 | P18893 (/IDA) |
Positive regulation of receptor signaling pathway via JAK-STAT GO:0046427
Any process that activates or increases the frequency, rate or extent of the JAK-STAT signaling pathway activity.
|
1 | P18893 (/ISO) |
Positive regulation of cytokine secretion GO:0050715
Any process that activates or increases the frequency, rate or extent of the regulated release of cytokines from a cell.
|
1 | P18893 (/ISO) |
Negative regulation of inflammatory response GO:0050728
Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response.
|
1 | P29456 (/IDA) |
Negative regulation of inflammatory response GO:0050728
Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response.
|
1 | P18893 (/IMP) |
Negative regulation of inflammatory response GO:0050728
Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response.
|
1 | P18893 (/ISO) |
Regulation of synapse organization GO:0050807
Any process that modulates the physical form of a synapse, the junction between a neuron and a target (neuron, muscle, or secretory cell).
|
1 | P29456 (/IDA) |
Regulation of synapse organization GO:0050807
Any process that modulates the physical form of a synapse, the junction between a neuron and a target (neuron, muscle, or secretory cell).
|
1 | P18893 (/ISO) |
Negative regulation of membrane protein ectodomain proteolysis GO:0051045
Any process that stops, prevents, or reduces the frequency, rate or extent of membrane protein ectodomain proteolysis.
|
1 | P18893 (/ISO) |
Positive regulation of DNA-binding transcription factor activity GO:0051091
Any process that activates or increases the frequency, rate or extent of activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
|
1 | P18893 (/ISO) |
Response to glucocorticoid GO:0051384
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects.
|
1 | P29456 (/IEP) |
Response to glucocorticoid GO:0051384
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects.
|
1 | P18893 (/ISO) |
Regulation of sensory perception of pain GO:0051930
Any process that modulates the frequency, rate or extent of the sensory perception of pain, the series of events required for an organism to receive a painful stimulus, convert it to a molecular signal, and recognize and characterize the signal.
|
1 | P29456 (/IDA) |
Regulation of sensory perception of pain GO:0051930
Any process that modulates the frequency, rate or extent of the sensory perception of pain, the series of events required for an organism to receive a painful stimulus, convert it to a molecular signal, and recognize and characterize the signal.
|
1 | P18893 (/ISO) |
Negative regulation of cytokine activity GO:0060302
Any process that decreases the rate, frequency or extent of the activity of a molecule that controls the survival, growth, differentiation and effector function of tissues and cells.
|
1 | P18893 (/ISO) |
Branching involved in labyrinthine layer morphogenesis GO:0060670
The process in which the branches of the fetal placental villi are generated and organized. The villous part of the placenta is called the labyrinth layer.
|
1 | P18893 (/IMP) |
Cellular response to lipopolysaccharide GO:0071222
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
1 | P18893 (/IDA) |
Cellular response to estradiol stimulus GO:0071392
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
|
1 | P29456 (/IEP) |
Liver regeneration GO:0097421
The regrowth of lost or destroyed liver.
|
1 | P29456 (/IEP) |
Positive regulation of pri-miRNA transcription by RNA polymerase II GO:1902895
Any process that activates or increases the frequency, rate or extent of pri-miRNA transcription mediated by RNA polymerase II.
|
1 | P18893 (/IDA) |
Regulation of response to wounding GO:1903034
Any process that modulates the frequency, rate or extent of response to wounding.
|
1 | P18893 (/IMP) |
Negative regulation of hydrogen peroxide-induced neuron death GO:1903208
Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide-induced neuron death.
|
1 | P18893 (/IGI) |
Positive regulation of sprouting angiogenesis GO:1903672
Any process that activates or increases the frequency, rate or extent of sprouting angiogenesis.
|
1 | P18893 (/IMP) |
Negative regulation of sensory perception of pain GO:1904057
Any process that stops, prevents or reduces the frequency, rate or extent of sensory perception of pain.
|
1 | P29456 (/IDA) |
Negative regulation of sensory perception of pain GO:1904057
Any process that stops, prevents or reduces the frequency, rate or extent of sensory perception of pain.
|
1 | P18893 (/ISO) |
Negative regulation of vascular smooth muscle cell proliferation GO:1904706
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell proliferation.
|
1 | P18893 (/IGI) |
Negative regulation of endothelial cell apoptotic process GO:2000352
Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell apoptotic process.
|
1 | P18893 (/IGI) |
There are 6 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
37 |
A2T6Z6 (/ISS)
P29456 (/ISS)
P43480 (/ISS)
P46651 (/ISS)
P47965 (/ISS)
P48411 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
P51496 (/ISS)
(27 more) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
7 | P18893 (/IDA) P22301 (/IDA) P22301 (/IDA) P22301 (/IDA) P29456 (/IDA) Q29408 (/IDA) Q6H8Q2 (/IDA) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
3 | P48411 (/NAS) P51746 (/NAS) Q29408 (/NAS) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
3 | P22301 (/TAS) P22301 (/TAS) P22301 (/TAS) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
2 | Q6A2H4 (/IDA) Q6A2H4 (/IDA) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
1 | P18893 (/ISO) |